- Home
- MNOV vs BDSX Comparison
MNOV vs BDSX Comparison
Compare MNOV & BDSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNOV
- BDSX
- Stock Information
- Founded
- MNOV 2000
- BDSX 2005
- Country
- MNOV United States
- BDSX United States
- Employees
- MNOV N/A
- BDSX N/A
- Industry
- MNOV Biotechnology: Pharmaceutical Preparations
- BDSX Precision Instruments
- Sector
- MNOV Health Care
- BDSX Health Care
- Exchange
- MNOV Nasdaq
- BDSX Nasdaq
- Market Cap
- MNOV 65.7M
- BDSX 61.9M
- IPO Year
- MNOV 2005
- BDSX 2020
- Fundamental
- Price
- MNOV $1.22
- BDSX $6.63
- Analyst Decision
- MNOV Strong Buy
- BDSX Strong Buy
- Analyst Count
- MNOV 2
- BDSX 5
- Target Price
- MNOV $7.00
- BDSX $32.50
- AVG Volume (30 Days)
- MNOV 24.9K
- BDSX 52.8K
- Earning Date
- MNOV 11-12-2025
- BDSX 10-31-2025
- Dividend Yield
- MNOV N/A
- BDSX N/A
- EPS Growth
- MNOV N/A
- BDSX N/A
- EPS
- MNOV N/A
- BDSX N/A
- Revenue
- MNOV $134,599.00
- BDSX $76,556,000.00
- Revenue This Year
- MNOV N/A
- BDSX $18.80
- Revenue Next Year
- MNOV N/A
- BDSX $27.76
- P/E Ratio
- MNOV N/A
- BDSX N/A
- Revenue Growth
- MNOV N/A
- BDSX 25.70
- 52 Week Low
- MNOV $1.13
- BDSX $3.44
- 52 Week High
- MNOV $2.55
- BDSX $34.40
- Technical
- Relative Strength Index (RSI)
- MNOV 41.14
- BDSX 51.83
- Support Level
- MNOV $1.23
- BDSX $6.33
- Resistance Level
- MNOV $1.26
- BDSX $7.81
- Average True Range (ATR)
- MNOV 0.03
- BDSX 0.54
- MACD
- MNOV -0.00
- BDSX -0.39
- Stochastic Oscillator
- MNOV 16.67
- BDSX 9.36
About MNOV Medicinova Inc
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's strategies are to focus its developing activities on therapeutics for neurological disorders and fibrotic diseases.
About BDSX Biodesix Inc.
Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.